Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
批准号:
8292232
负责人:
Robert L. Carolla
金额:
$73.11万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-15 至 2014-05-31
关键词:
African AmericanAreaAsian AmericansAwarenessCancer ControlCancer Prevention TrialCancer Research ProjectClinical TrialsCommitCommunitiesCommunity Clinical Oncology ProgramControlled StudyDataDevelopmentEnrollmentEventFeedbackFutureGoalsGrantHealthHealth systemHealthcare SystemsHispanicsIndividualInstructionLeadershipMalignant NeoplasmsMarketingMinorityMinority GroupsMissionMissouriMonitorNative AmericansNursing Administration ResearchNursing ResearchOncologistOzarksParticipantPatient ParticipationPatientsPhysiciansPopulationPreventionPrimary Health CareProtocols documentationQualifyingQuality of CareRadiation OncologistRecommendationRecruitment ActivityRegistered nurseReportingResearchResearch PersonnelResourcesRural CommunityScheduleScreening for cancerScreening procedureSiteSpecialistSurgeonTeam NursingTestingTimeTrainingUrologistValidity and Reliabilityanticancer researchbasecancer carecancer therapycontrol trialmeetingsmemberoncologypreventprogramsquality assurancesymposiumtherapy developmenttreatment trial
中文摘要
20多年来,Ozarks癌症研究(CRO)提供了NCI批准的临床试验
到西南部密苏里州和周边地区的农村社区。通过有远见的
领导医生温德尔古德温,医学博士和罗伯特L。Mrsella,MD,否则患者
无法参与临床试验的人可以选择通过社区临床试验
肿瘤学项目。
从一开始,CRO就得到了两个国家认可的医疗保健系统的支持,
考克斯健康和圣约翰卫生系统在斯普林菲尔德,密苏里州。后来又加了两个
Joplin附属公司,CRO现在提供该地区95%以上的癌症护理资源
包括一个由肿瘤学家、放射肿瘤学家、妇科肿瘤学家组成的医生网络,
泌尿科医生、外科医生和初级保健专家。
CRO支持CCOP加快制定干预措施以预防和治疗癌症的使命
增加试验的累积费用。CRO超过5%的患者参与,
在过去五年中,每年都有患者参加治疗和预防及控制试验。
CRO的33名医生研究者积极参与该计划,提高认识
治疗、控制和预防方面的最新发展以及
社区CRO还成功地增加了少数民族的参与,
比一般癌症患者的比例高。
相关性(参见说明!:
研究是人类的未来。奥扎克癌症研究中心沿着提供NCI肿瘤治疗
带着癌症控制和预防试验到斯普林菲尔德和周边社区。最终目标
就是找到治愈癌症的方法
英文摘要
For over 20 years, Cancer Research for the Ozarks (CRO) has provided NCI-approved clinical trials
to the rural communities of Southwestern Missouri and surrounding areas. Through the visionary
leadership of physicians Wendall Goodwin, MD and Robert L. Carolla, MD, patients who otherwise
would not have access to clinical trials can elect to participate through the Community Clinical
Oncology Program.
From its inception, CRO has had the support of the two nationally recognized health care systems,
CoxHealth and St. John's Health System in Springfield, Missouri. With the later addition of two
Joplin affiliates, CRO now provides more than 95 percent of cancer care resources in the area
including a physician network of oncologists, radiation oncologists, gynecological oncologists,
urologists, surgeons, and primary care specialists.
CRO supports the CCOP mission of accelerating development of interventions to prevent and treat
cancer by increasing accruals to trials. CRO exceeds five percent patient participation with over 200
patients enrolled to treatment and prevention and control trials each of the past five years.
CRO's thirty-three physician investigators actively participate in the program increasing awareness
of recent developments in treatment, control and prevention and the overall quality of care in the
community. CRO has also successfully increased involvement of minorities enrolling a higher
percentage than that of the general cancer population.
RELEVANCE (See instructions!:
Research is the future of mankind. Cancer Research for the Ozarks offers NCI oncology treatment along
with cancer control and prevention trials to Springfield and the surrounding communities. The ultimate goal
of participation is to find the cure for cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
-
批准号:7656945
-
项目类别:
-
资助金额:$56.14万
-
财政年份:1987
-
负责人:Robert L. Carolla
-
依托单位:
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
-
批准号:8081833
-
项目类别:
-
资助金额:$58.91万
-
财政年份:1987
-
负责人:Robert L. Carolla
-
依托单位:
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
-
批准号:7849957
-
项目类别:
-
资助金额:$46.14万
-
财政年份:1987
-
负责人:Robert L. Carolla
-
依托单位:
Cancer Research for the Ozarks
-
批准号:7494116
-
项目类别:
-
资助金额:$68.14万
-
财政年份:1987
-
负责人:Robert L. Carolla
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: